|
Showing the most relevant articles for your search:NASDAQ:AVXS | Date | Time | Source | Headline | Symbol | Company | | 02/14/2017 | 6:11PM | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 02/14/2017 | 11:43AM | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 02/14/2017 | 10:50AM | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 02/07/2017 | 4:19PM | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 02/06/2017 | 8:27AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 02/06/2017 | 8:00AM | GlobeNewswire Inc. | AveXis Announces Single-Arm Design for European Pivotal Study of AVXS-101 in SMA Type 1 Patients | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 02/02/2017 | 11:39AM | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 02/02/2017 | 10:29AM | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 02/01/2017 | 10:15AM | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 01/31/2017 | 8:00AM | GlobeNewswire Inc. | AveXis Gene Therapy AVXS-101 Granted Access into EMA PRIME Program for Spinal Muscular Atrophy Type 1 | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 01/30/2017 | 11:31AM | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 01/09/2017 | 9:16AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 01/03/2017 | 8:00AM | GlobeNewswire Inc. | AveXis to Present at the 35th Annual J.P. Morgan Healthcare Conference | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 12/23/2016 | 4:16PM | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 12/21/2016 | 4:08PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 12/21/2016 | 4:01PM | GlobeNewswire Inc. | AveXis to Use Intended Commercial GMP Product in SMA Type 2 Study | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 11/10/2016 | 4:14PM | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 11/10/2016 | 4:07PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 11/10/2016 | 4:01PM | GlobeNewswire Inc. | AveXis Reports Third Quarter 2016 Financial and Operating Results | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 11/10/2016 | 11:50AM | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 11/08/2016 | 8:00AM | GlobeNewswire Inc. | AveXis to Present at Jefferies 2016 London Healthcare Conference | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 11/01/2016 | 4:10PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 11/01/2016 | 4:01PM | GlobeNewswire Inc. | AveXis Announces Single-Arm Design for U.S. Pivotal Study of AVXS-101 in SMA Type 1 Patients | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 10/31/2016 | 8:00AM | GlobeNewswire Inc. | AveXis to Report Third Quarter 2016 Financial and Operating Results | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 10/11/2016 | 4:32PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 10/10/2016 | 7:00AM | GlobeNewswire Inc. | AveXis to Host Webcast Update of Data from Ongoing Phase 1 Clinical Trial of AVXS-101 in Spinal Muscular Atrophy Type 1 | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 10/08/2016 | 9:03AM | Business Wire | AveXis Reports Interim Data from Ongoing Phase 1 Clinical Trial of AVXS-101 in Spinal Muscular Atrophy Type 1 as Presented at... | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 09/15/2016 | 9:05AM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 09/12/2016 | 4:20PM | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(4) (424b4) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 09/08/2016 | 7:25AM | GlobeNewswire Inc. | AveXis Announces Pricing of Public Offering of Common Stock | NASDAQ:AVXS | Avexis, Inc. (delisted) |
|
Showing the most relevant articles for your search:NASDAQ:AVXS |
|